HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,971 | -7.3% | 126,117 | -1.7% | 0.26% | -19.8% |
| Q1 2023 | $13,999 | -31.1% | 128,264 | -28.2% | 0.33% | -43.2% |
| Q4 2022 | $20,329 | -99.2% | 178,637 | +336.5% | 0.58% | +761.2% |
| Q3 2022 | $2,533,000 | +91.2% | 40,927 | +146.3% | 0.07% | +67.5% |
| Q2 2022 | $1,325,000 | -76.9% | 16,615 | -69.5% | 0.04% | -69.7% |
| Q1 2022 | $5,724,000 | +27.0% | 54,409 | +30.1% | 0.13% | +29.4% |
| Q4 2021 | $4,506,000 | +2.5% | 41,818 | +4.2% | 0.10% | +7.4% |
| Q3 2021 | $4,395,000 | +14.0% | 40,119 | -2.6% | 0.10% | +11.8% |
| Q2 2021 | $3,856,000 | +5.5% | 41,183 | +3.7% | 0.08% | +6.2% |
| Q1 2021 | $3,655,000 | +16.2% | 39,712 | -7.6% | 0.08% | +31.1% |
| Q4 2020 | $3,145,000 | +12.5% | 43,000 | +19.4% | 0.06% | -18.7% |
| Q3 2020 | $2,796,000 | +357.6% | 36,000 | +227.3% | 0.08% | +316.7% |
| Q2 2020 | $611,000 | +118.2% | 11,000 | +16.5% | 0.02% | +63.6% |
| Q1 2020 | $280,000 | -57.1% | 9,439 | -47.6% | 0.01% | 0.0% |
| Q4 2019 | $652,000 | +40.8% | 18,000 | +5.9% | 0.01% | +22.2% |
| Q3 2019 | $463,000 | +13.2% | 17,000 | 0.0% | 0.01% | -18.2% |
| Q2 2019 | $409,000 | – | 17,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |